Fludarabine
AIDS
National Center for Global Health and Medicine, JapanSmall moleculeN/ADormant
D
30/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 15/ 100
- Competitive Position
- 95/ 100
Competitive context
0 Active assets in the AIDS cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
LACTO-FLAVIN Queen's University | Phase 4 | BB |
Thiamine Queen's University | Phase 4 | BB |
L-Carnitine Queen's University | Phase 4 | BB |
Dimiracetam Neurotune AG | Phase 2 | B |
Evomela National Center for Global Health and Medicine, Japan | N/A | D |
View all 13 →
Same molecule, other indications
Fludarabine is also rated in:
acute myeloid leukemia with abnormal bone marrow eosinophils inv(16)(p13q22) or t(16;16)(p13;q22)Dormant
BBB
Indicative ·
76 / 100
View asset →Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →